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Abstract
Background: Genital surgery in Disorders of Sex Development (DSD) has been an area of debate over the past
20 years. Emerging scientific evidence in the late 1990s defied the then routine practice to surgically align genitalia
to the sex of rearing, as early as possible. However, despite multitude of data showing detrimental effects to genital
sensation and sexuality, few patients born with ambiguous genitalia have remained unoperated into adolescence.
Methods: We followed up girls with 21 hydroxylase deficiency (21- OHD) in genital morphology during childhood
and acceptability among patients and parents of such an approach.
Results: Preliminary results from 7 children, aged 1–8 years (median 4.5 years), suggest that it is acceptable among
patients and families to defer genital operation in 21-OHD. All patients had a Prader stage III and above. Median
clitoral length at birth was 24 mm (20-28 mm) and had diminished to a median of 9 mm (5-15 mm) at their last
visit. Height and weight have remained strictly normal in all patients. So far girls and their parents have not
expressed significant concerns regarding genital ambiguity.
Conclusions: With this encouraging data at hand, we propose to formally address levels of anxiety, adaptation and
quality of life during childhood, with an ultimate goal to assess long term satisfaction and effects on sexuality
through deferring genital surgery for adolescence.
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Background
Surgical management in Disorders of Sex Development
(DSD) remains an area of controversy, even following
the 2005 Chicago consensus, which attempted to delin-
eate treatment guidelines and advocated a more cautious
approach to genital surgery [8]. For years, the norm in
DSD, was to align genitalia with the assigned gender as
early as possible. Supporters of early surgery have based
their practice on a need to reinforce sex of rearing, while
relieving parental tension regarding the ambiguity of the
genitalia [13]. Early surgery, when assessed in the imme-
diate postoperative period was thought to provide ideal
cosmetic and anatomical results, with the additional
benefit that a procedure performed early enough in
infancy would be forgotten by the patient.
It was not until the 1990s that this practice was
challenged by patients themselves, who came forward with
significant problems in adulthood, including anatomical
difficulties in penetrative sexual intercourse and decreased
genital sensation or ability to reach orgasm [15].
Multiple scientific voices have joined those of patients
and support groups to question long term results of
early genital surgery [5, 6, 12, 14]. Decreased genital
sensitivity and need for further surgery in adulthood, as
well as poor cosmetic results in the long run have been
proven by studies in multiple institutions, suggesting
dissatisfaction in a significant proportion of patients
irrespective of geographical provenance [2, 6, 11, 14].
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Despite concerns, inertia has perpetuated the practice
of early genital surgery into the present, and, to date,
there have been no series of patients left unoperated
until adolescence or adulthood so as to form a basis for
comparison. Current practice still favours early genital
surgery, usually based on nebulous and unproven scien-
tific facts, as shown by national statistics [7], audits of
practice among pediatric surgeons [16], and the paucity of
data on unoperated patients in series of 21-OHD patients.
Nevertheless, the handful of DSD patients that have
remained unoperated, seem to have similar genital sensa-
tion to normal controls, with numbers however remaining
too small to draw firm conclusions on [4]. With evidence
on long term outcomes lacking, it is impossible to formu-
late a well-supported scientific argument for deferring
genital operation.
Methods
During the last decade, our institution, a tertiary referral
centre for complex paediatric endocrinological disorders,
has had a policy of offering unbiased information regard-
ing the pros and cons of genital operation to all parents of
children born with 21- hydroxylase deficiency and Prader
III-IV stages. Parents are given the opportunity to discuss
the care of their child with a paediatric endocrinologist, a
gynaecologist with expertise in paediatric and adolescent
care and if requested, a paediatric urologist. The child and
parents are followed at regular intervals irrespective of
whether they have opted for surgery or not. During visits,
we assess the child’s behaviour, her interaction with her
parents, evaluate for the presence of parental anxiety and
note down any evidence of disruption to everyday activities
due to the ambiguous appearance of the genitalia, urinary
symptoms or clitoral erections.
Results
We are currently following seven 21-OHD girls with a
median age of 4.5 years (range 1–8 years) whose operation
has been deferred.
The first girl, named GK, was born 8 years ago. She was
left unoperated following a decision from the parents and
PB. After observing the girl during one year, it was clear
that the length of the clitoris could be minimized with
50 mg hydrocortisone/m2 daily in four divided doses,
bring serum testosterone and delta-4-androstenedione
levels to under 0.02 ng/ml. Over the following years, GK’s
parents did not express any concern regarding the
psychological or physical well-being of their child, despite
episodic clitoral erections.
Since GK’s experience was encouraging, this pilot 2-year
observation was shared with CB and MC who used it to
inform other parents. From 2010 to 2015, CB and MC
have been following 6 more girls with 21-OHD, born with
Prader III-IV stages, who were left unoperated. These girls
are followed up closely, with regards to their growth
pattern, the degree of change in clitoral size and their
psycho-developmental adjustment. So far all girls and
their parents have not expressed significant concerns
regarding genital ambiguity, despite episodic clitoral erec-
tions. There have been no cases of urinary track infec-
tions. Median clitoral length in this group of patients at
birth was 25 mm (range 20-28 mm), whereas at their last
visit median length was 9 mm (range 5-15 mm p < 0.001,
Wilcoxon signed rank test). Growth rate, height and
weight have remained strictly normal in all patients
(Fig. 1). The main characteristics of the seven girls are
depicted in Table 1. Figures 2 and 3 shows the results of
the treatment at age 1 month in girl ON followed by MC.
Treatment in all girls was started at a dosage of 50 mg/m2
daily in four divided doses, a higher dosage than usually
recommended, for the first year of life and 50 μg fludro-
cortisone administered twice daily, and 2gr NaCL daily
divided in four doses.. Thereafter, the daily dosage of
hydrocortisone was gradually reduced to an average of
40 mg/m2 for the second year of life and 10-25 mg/m2
from the third year of life onwards. The doses of hydro-
cortisone that we used are closer to the Japanese [9] than
to the European or American guidelines [10].
Discussion
The audit of our small series demonstrates that, at least
in childhood, and with appropriate medical care and
psychological support, it is possible to defer genital
surgery. Whilst so far no major concerns have been
reported from patients and their families, it remains
unclear whether patients will continue to accept their
diversity as they grow.
Clitoromegaly may be obvious enough to peers and may
become the element and basis of bullying. One would
have to put this in context of the current vogue among
‘normal’ women (with no genital ambiguity) to readily
explore their genital area and opt for plastic surgery to
their normal labia minora or clitoral prepuce, in order to
diminish tissue that protrudes in the genital region [3]. In
this current trend, a girl growing with clitoromegaly and
ambiguous genitalia should be under frequent psycho-
logical support to enable better understanding of the con-
dition and reinforce strategies to cope with being diverse.
Nevertheless, the degree of clitoromegaly may not be
accurately assessed at birth as the newborn’s genitals are
under the full influence of adrenal androgens and mater-
nal oestrogens. Although clitoromegaly is not reversible,
anecdotal reports and our experience suggest that the
clitoris could decrease in size as higher doses of
glucocorticoid and mineralocorticoid replacement are
instituted for the first year of life. Furthermore, as the
child grows the relative larger size of the clitoris might
become less evident.
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A personalized regimen of glucocorticoids needs to be
defined within the therapeutic window, maintaining
complete suppression of androstenedione and testoster-
one production and avoiding the unwanted effects of
chronic hypercorticism. Individualized dosage and daily
administration timing should be defined pragmatically in
each patient instead of a per kg dogmatic prescription
expected to fit all cases.
Compliance to medication is a reported concern in
21-OHD, particularly when adolescents start to be more
rebellious and independent, omitting dosages or resisting
and resenting treatment all together. This explains why
a proportion of patients operated in childhood may need
revisions to the clitoris in adolescence because of regrowth
of tissue in puberty, due to a resurgence of androgens. With
this in mind a stricter control with more frequent visits
and better psychological support would be required in
adolescence [1].
When the girl reaches adolescence, an examination
under anaesthesia, a cystoscopy and vaginoplasty will
allow for an accurate evaluation of the girl’s genitalia,
including measuring the width and length of the clitoris
and assessing the distance of the urethral and vaginal
confluence to the perineum and the caliber of the
vagina. This examination is usually organized on a day
surgery basis and can easily be accommodated around
school commitments, so as to interfere to a minimum
with the lifestyle of the girl.
Fig. 1 Growth curve for height and weight of 4 girls (GK, LC, DW, LM) and 3 babies. Heights of father (F) and mother (M)

















GK yes 3-4 25 257 8 8 15 +0.2
LC yes 3-4 20 119 9.8 7 7 −0.3
LM no 3-4 20 414 14 5.5 5 +0.3
DW yes 3-4 20 150 9 4.5 5 +0.4
CL no 3-4 25 49 14 1 10 +0.4
CC no 3-4 25 14 6.5 1 15 0
ON yes 4 28 230 14.8 1 9 0
aSD departure from height for age calculated from mid-parental target height
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A vaginoplasty performed in adolescence is technically
similar to the one performed in infancy. Advantages in
adolescence are the larger caliber of the proximal vagina,
allowing for a better end result at the level of anastomosis.
Certainly the presence of oestrogens should allow for easier
tissue plane identification and postoperative healing. Further
to these technical advantages, an adolescent is in a better
position to perform postoperative vaginal dilation, which
will be required to avoid the formation of strictures, a com-
plication often reported in the literature in as high as 50% of
patients having had a vaginoplasty in childhood [2, 5, 6, 11].
Irrespective of potential technical benefits of performing
surgery later in life, a major ethical advantage stems from
the fact that the patient herself can be involved in the
decision to proceed or not with an operation to the clitoris,
taking into account the implications of surgery, the benefits
to appearance and the possible risks to genital sensation
and sexual function. It is perceived that a number of
patients may opt against surgery all together as they grow,
either because of a decreased size of the clitoris (relative or
true) or because of a concern of effects of surgery on genital
sensitivity. In either case it can be her choice to proceed to
a clitoral reduction, even if the parent or guardian still has
the legal responsibility for the operation.
We will collect preliminary results over the next few
years, regarding concerns stemming from the ambiguity
of the genitalia during childhood. However, the final
outcome of a study should be long term adjustment,
both with regards to sexuality and quality of life. It is
obvious that these results will be available fifteen to
twenty years from now, when current infants with 21-
OHD will be entering adolescence and adulthood. De-
velopment of a prospective study with long follow up
needs planning not only with regards to a well-designed
protocol and measures to decrease dropout rates and
patients lost to follow up. We also need to provide con-
tinuity of care within our service, to the next generation
Fig. 2 Aspects of external genitalia of ON at birth
Fig. 3 External genitalia at two months of age
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of researchers and clinicians, the current trainees or
young specialists that will be gathering and analyzing
results in the future.
Conclusions
Preliminary results in 7 young girls now aged 1–8 years
affected with 21-OHD and born with Prader III-IV stages
suggest that deferring genital operation is acceptable among
patients and families. A careful medical treatment allowed the
decrease of median clitoral length from 24 mm at birth to
9 mm at their last visit. So far girls and their parents have not
expressed significant concerns regarding genital ambiguity.
With these encouraging data at hand, we propose to
formally address levels of anxiety, adaptation and quality
of life during childhood, with an ultimate goal to assess
long- term satisfaction and effects on sexuality through
deferring genital surgery for adolescence. These observa-
tions may pave the way for a new management of the
disease in a subset of patients.
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